# Umbilical Cord Mesenchymal Stem Cells for Patients With Liver Cirrhosis

> **NCT01220492** · PHASE1,PHASE2 · COMPLETED · sponsor: **Beijing 302 Hospital** · enrollment: 266 (actual)

## Conditions studied

- Liver Cirrhosis

## Interventions

- **DRUG:** conventional plus MSC treatment
- **DRUG:** conventional plus placebo treatment

## Key facts

- **NCT ID:** NCT01220492
- **Lead sponsor:** Beijing 302 Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2016-04
- **Final completion:** 2016-04
- **Target enrollment:** 266 (ACTUAL)
- **Last updated:** 2018-08-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01220492

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01220492, "Umbilical Cord Mesenchymal Stem Cells for Patients With Liver Cirrhosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01220492. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*